Different regulatory and cytotoxic CD4+ T lymphocyte profiles in renal transplants with antibody-mediated chronic rejection or long-term good graft function

Transplant Immunology

Volumn 28, Issue 1, 2013, Pages 48-56

  Giaretta, Fulvia ^a   Bussolino, Stefania ^a   Beltramo, Silvia ^a,b   Fop, Fabrizio ^a   Rossetti, Maura ^a   Messina, Maria ^a   Cantaluppi, Vincenzo ^a,b   Ranghino, Andrea ^a   Basso, Elisa ^a   Camussi, Giovanni ^a,b   Segoloni, Giuseppe Paolo ^a   Biancone, Luigi ^a,b  

^a UNIVERSITY OF TURIN   (Italy)

^b MOLINETTE HOSPITAL   (Italy)

Author keywords

Cytotoxicity; Kidney transplantation; Lymphocyte; Tolerance

Indexed keywords

CD27 ANTIGEN; CD28 ANTIGEN; CD45RO ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GRANZYME B; TRANSCRIPTION FACTOR FOXP3;

ADULT; AGED; ANTIBODY MEDIATED CHRONIC REJECTION; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CHRONIC GRAFT REJECTION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; HUMAN; HUMAN CELL; IMMUNOLOGICAL MEMORY; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE;

ADULT; AGED; ANTIBODIES; CD4-POSITIVE T-LYMPHOCYTES; CELL COMMUNICATION; CHRONIC DISEASE; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; HUMANS; IMMUNOPHENOTYPING; ISOANTIGENS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; T-LYMPHOCYTES, CYTOTOXIC; T-LYMPHOCYTES, REGULATORY; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84873055361     PISSN: 09663274     EISSN: 18785492     Source Type: Journal    
DOI: 10.1016/j.trim.2012.11.003     Document Type: Article

References (48)

1. Sakaguchi S., Sakaguchi N., Asano M., Itoh M., Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25): Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995, 155:1151-1164.
2. Hori S., Nomura T., Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003, 299:1057-1061.
3. + T cells in human kidney transplant recipients. J Am Soc Nephrol 2003, 14:1643-1651.
4. Ziegler S.F. FOXP3: of mice and men. Annu Rev Immunol 2006, 24:209-226.
5. Bennett C.L., Christie J., Ramsdell F., et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 2001, 27:20-21.
6. + regulatory T cells synergize with host T-cell depletion to promote long-term survival of allografts. Am J Transplant 2008, 8:298-306.
7. Brown K., Wong W. Diagnostic value of regulatory T cells: a new facet of a much studied cell population. Transplantation 2008, 86:1485-1491.
8. Eagar T.N., Karandikar N.J., Bluestone J.A., Miller S.D. The role of CTLA-4 in induction and maintenance of peripheral T cell tolerance. Eur J Immunol 2002, 32:972-981.
9. + regulatory T cells mediates by GITR molecules. Immunol Lett 2008, 121:97-104.
10. + T reg cells. J Exp Med 2006, 203:1701-1711.
11. Baecher-Allan C., Wolf E., Hafler D.A. MHC class II expression identifies functionally distinct human regulatory T cells. J Immunol 2006, 176:4622-4631.
12. Ruggenenti P., Perico N., Gotti E., et al. Sirolimus versus cyclosporine therapy increases circulating regulatory T cells, but does not protect renal transplant patients given alemtuzumab induction from chronic allograft injury. Transplantation 2007, 84:956-964.
13. +T cells/FOXP3 patterns in chronic rejection and operational drug-free tolerance. Transplantation 2006, 81:398-407.
14. +CD25high regulatory T cells. Blood 2004, 103:2410-2416.
15. + T-cells. Nephrol Dial Transplant 2009, 24:1969-1978.
16. + T lymphocytes in culture. Nature 1984, 308:365-367.
17. + human cytolytic T cells specific for HIV-infected cells by gp160 subunite vaccine. Science 1990, 248:1234-1237.
18. Appay V., Zaunders J.J., Papagno L., et al. Characterization of CD4(+) CTLs ex vivo. J Immunol 2002, 168:5954-5958.
19. Appay V., Van Lier R.A., Sallusto F., Roederer M. Phenotype and function of human T lymphocyte subsets: consensus and issues. Cytometry A 2008, 73:975-983.
20. Cai S.F., Fehniger T.A., Cao X., et al. Differential expression of granzyme B and C in murine cytotoxic lymphocytes. J Immunol 2009, 182:6287-6297.
21. Hidalgo L.G., Einecke G., Allanach K., et al. The transcriptome of human cytotoxic T cells: measuring the burden of CTL-associated transcripts in human kidney transplants. Am J Transplant 2008, 8:637-646.
22. + CTL that utilizes a perforin, rather than a Fas ligand-dependent cytotoxic mechanism. J Immunol 1996, 156:153-159.
23. Aquino-Dias E.C., Joelsons G., da Silva D.M., et al. Non-invasive diagnosis of acute rejection in kidney transplants with delayed graft function. Kidney Int 2008, 73:877-884.
24. Solez K., Colvin R.B., Racusen L.C., et al. Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant 2008, 8:753-760.
25. Joosten S.A., Sijpkens Y.W., van Kooten C., Paul L.C. Chronic renal allograft rejection: pathophysiologic considerations. Kidney Int 2005, 68:1-13.
26. Ashoor I.F., Najafian N. Rejection and regulation: a tight balance. Curr Opin Organ Transplant 2012, 17:1-7.
27. Ramírez E., Morales J.M., Lora D., et al. Peripheral blood regulatory T cells in long-term kidney transplant recipients. Transplant Proc 2009, 41:2360-2362.
28. Fontenot J.D., Gavin M.A., Rudensky A.Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 2003, 4:330-336.
29. Yagi H., Nomura T., Nakamura K., et al. Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells. Int Immunol 2004, 16:1643-1656.
30. Chauhan S.K., Saban D.R., Lee H.K., Dana R. Levels of Foxp3 in regulatory T cells reflect their functional status in transplantation. J Immunol 2009, 182:148-153.
31. Tai X., Van Laethem F., Pobezinsky L., et al. Basis of CTLA-4 function in regulatory and conventional CD4+ T cells. Blood 2012, 119:5155-5163.
32. Catalfamo M., Tai X., Karpova T., McNally J., Henkart P.A. TcR-induced regulated secretion leads to surface expression of CTLA-4 in CD4+CD25+ T cells. Immunology 2008, 125:70-79.
33. Takata Y., Nakamoto Y., Nakada A., et al. Frequency of CD45RO+ subset in CD4+CD25(high) regulatory T cells associated with progression of hepatocellular carcinoma. Cancer Lett 2011 Aug 28, 307(2):165-173.
34. Mailloux A.W., Sugimori C., Komrokji R.S., et al. Expansion of effector memory regulatory T cells represents a novel prognostic factor in lower risk myelodysplastic syndrome. J Immunol 2012, 189:3198-3208.
35. Denoeud J., Moser M. Role of CD27/CD70 pathway of activation in immunity and tolerance. J Leukoc Biol 2011, 89:195-203.
36. De Serres S.A., Sayegh M.H., Najafian N. Immunosuppressive drugs and Tregs: a critical evaluation!. Clin J Am Soc Nephrol 2009, 4:1661-1669.
37. Bluestone J.A., Liu W., Yabu J.M., et al. The effect of costimulatory and interleukin 2 receptor blockade on regulatory T cells in renal transplantation. Am J Transplant 2008, 8:2086-2096.
38. Seder R.A., Ahmed R. Similarities and differences in CD4+ and CD8+ effector and memory T cell generation. Nat Immunol 2003, 4:835-842.
39. Macedo C., Orkis E.A., Popescu I., et al. Contribution of naïve and memory T-cell populations to the human alloimmune response. Am J Transplant 2009, 9:2057-2066.
40. Casazza J.P., Betts M.R., Price D.A., et al. Acquisition of direct antiviral effector functions by CMV-specific CD4+ T lymphocytes with cellular maturation. J Exp Med 2006, 203:2865-2877.
41. + T cells in human cytomegalovirus infection. Hum Immunol 2004, 65:486-492.
42. + T cells directly recognize allogeneic endothelial cells in vitro and in vivo. J Immunol 2007, 179:4397-4404.
43. Grazia T.J., Plenter R.J., Weber S.M., et al. Acute cardiac allograft rejection by directly cytotoxic CD4 T cells: parallel requirements for Fas and Perforin. Transplantation 2010, 89:33-39.
44. + effector regulatory T cell activity via Granzyme B. J Immunol 2009, 183:4843-4847.
45. Yasukawa M., Ohmiami H., Arai J., Kasahara Y., Ishida Y., Fujita S. Granule exocytosis, and not the fas/fas ligand system, is the main pathway of cytotoxicity mediated by alloantigen-specific CD4(+) as well as CD8(+) cytotoxic T lymphocytes in humans. Blood 2000, 95:2352-2355.
46. + T lymphocytes: analysis using the combination of hereditary perforin-deficient effector cells and Fas-deficient target cells. J Immunol 2003, 170:2205-2213.
47. Yoshida H., Maeda T., Ishikawa J., et al. Expression of CD27 on peripheral CD4+ T-lymphocytes correlates with the development of severe acute graft-versus-host disease after allogeneic bone marrow transplantation. Int J Hematol 2006, 84:367-376.
48. Glouchkova L., Ackermann B., Zibert A., et al. The CD70/CD27 pathway is critical for stimulation of an effective cytotoxic T cell response against B cell precursor acute lymphoblastic leukemia. J Immunol 2009, 182:718-725.